Welcome to Aurobindo Pharma USA: Committed to healthier life.

Important News:

March 22, 2017

Aurobindo received FDA approval for Guaifenesin and Dextromethorphan Hydrobromide Extended-Release Tablets (OTC), 600/30 mg and 1200/60 mg.

February 27, 2017

GPhA changes name to the Association for Accessible Medicines

Its new identity will improve recognition that the generic and biosimilar medicines industry is one of “the nation’s great health care success stories, and that competition […]